226 related articles for article (PubMed ID: 32960068)
1. Influence of Bile Composition on Membrane Incorporation of Transient Permeability Enhancers.
Hossain S; Joyce P; Parrow A; Jõemetsa S; Höök F; Larsson P; Bergström CAS
Mol Pharm; 2020 Nov; 17(11):4226-4240. PubMed ID: 32960068
[TBL] [Abstract][Full Text] [Related]
2. In Silico-Based Experiments on Mechanistic Interactions between Several Intestinal Permeation Enhancers with a Lipid Bilayer Model.
Kneiszl R; Hossain S; Larsson P
Mol Pharm; 2022 Jan; 19(1):124-137. PubMed ID: 34913341
[TBL] [Abstract][Full Text] [Related]
3. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the physicochemical interactions between exenatide and two intestinal permeation enhancers: Sodium caprate (C
Twarog C; Fattal E; Noiray M; Illel B; Brayden DJ; Taverna M; Hillaireau H
Int J Pharm; 2022 Oct; 626():122131. PubMed ID: 36028084
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of colonic drug absorption by the transcellular permeation route.
Tomita M; Hayashi M; Horie T; Ishizawa T; Awazu S
Pharm Res; 1988 Dec; 5(12):786-9. PubMed ID: 3247289
[TBL] [Abstract][Full Text] [Related]
6. Impact of Sodium
Li Y; Yang D; Zhu C
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
[TBL] [Abstract][Full Text] [Related]
7. Absorption enhancement, mechanistic and toxicity studies of medium chain fatty acids, cyclodextrins and bile salts as peroral absorption enhancers.
Sharma P; Varma MV; Chawla HP; Panchagnula R
Farmaco; 2005; 60(11-12):884-93. PubMed ID: 16226752
[TBL] [Abstract][Full Text] [Related]
8. Safety concerns over the use of intestinal permeation enhancers: A mini-review.
McCartney F; Gleeson JP; Brayden DJ
Tissue Barriers; 2016; 4(2):e1176822. PubMed ID: 27358756
[TBL] [Abstract][Full Text] [Related]
9. Intestinal Permeation Enhancers for Oral Delivery of Macromolecules: A Comparison between Salcaprozate Sodium (SNAC) and Sodium Caprate (C
Twarog C; Fattah S; Heade J; Maher S; Fattal E; Brayden DJ
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781867
[TBL] [Abstract][Full Text] [Related]
10. Interaction between Permeation Enhancers and Lipid Bilayers.
Kang C; Bernaldez M; Stamatis SD; Rose JP; Sun R
J Phys Chem B; 2024 Feb; 128(7):1668-1679. PubMed ID: 38232311
[TBL] [Abstract][Full Text] [Related]
11. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
[TBL] [Abstract][Full Text] [Related]
12. Do Macrocyclic Peptide Drugs Interact with Bile Salts under Simulated Gastrointestinal Conditions?
Dening TJ; Douglas JT; Hageman MJ
Mol Pharm; 2021 Aug; 18(8):3086-3098. PubMed ID: 34255531
[TBL] [Abstract][Full Text] [Related]
13. Revealing the interaction between peptide drugs and permeation enhancers in the presence of intestinal bile salts.
Hossain S; Kneiszl R; Larsson P
Nanoscale; 2023 Dec; 15(47):19180-19195. PubMed ID: 37982184
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence study of the membrane-perturbing action of sodium caprylate as related to promotion of drug absorption.
Kajii H; Horie T; Hayashi M; Awazu S
J Pharm Sci; 1988 May; 77(5):390-2. PubMed ID: 3411458
[TBL] [Abstract][Full Text] [Related]
16. Molecular Dynamics Simulations on Interindividual Variability of Intestinal Fluids: Impact on Drug Solubilization.
Parrow A; Larsson P; Augustijns P; Bergström CAS
Mol Pharm; 2020 Oct; 17(10):3837-3844. PubMed ID: 32787279
[TBL] [Abstract][Full Text] [Related]
17. Reversible increase in tight junction permeability to macromolecules in rat ileal mucosa in vitro by sodium caprate, a constituent of milk fat.
Söderholm JD; Oman H; Blomquist L; Veen J; Lindmark T; Olaison G
Dig Dis Sci; 1998 Jul; 43(7):1547-52. PubMed ID: 9690393
[TBL] [Abstract][Full Text] [Related]
18. SNAC for Enhanced Oral Bioavailability: An Updated Review.
Kommineni N; Sainaga Jyothi VGS; Butreddy A; Raju S; Shapira T; Khan W; Angsantikul P; Domb AJ
Pharm Res; 2023 Mar; 40(3):633-650. PubMed ID: 36539668
[TBL] [Abstract][Full Text] [Related]
19. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside.
Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A
J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081
[TBL] [Abstract][Full Text] [Related]
20. Micellar aggregation and membrane partitioning of bile salts, fatty acids, sodium dodecyl sulfate, and sugar-conjugated fatty acids: correlation with hemolytic potency and implications for drug delivery.
Ross BP; Braddy AC; McGeary RP; Blanchfield JT; Prokai L; Toth I
Mol Pharm; 2004; 1(3):233-45. PubMed ID: 15981926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]